San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Mirati Narrows Focus to Fewer Forms of Cancer

BIOTECH: FDA Grants Orphan Drug Status to Promising New Therapy

Mirati Therapeutics Inc., a public company in San Diego developing medicines for targeted oncology, is one step closer to achieving regulatory approval for its cancer drug Mocetinostat.

Tease photo

Ligand Signs Licensing Agreement With Georgia Company

Ligand Pharmaceuticals Inc. announced the signing of a commercial license agreement with Atlanta, Georgia-based Avion Pharmaceuticals LLC for the development and commercialization of four Captisol-enabled programs

Thermo Fisher Gets $9.1M Defense Deal, Work to Be Done in San Diego

The Defense Department said on Aug. 14 that it awarded a $9.1 million contract modification to Thermo Fisher Scientific to acquire reagents and consumables for its DNA Identification Laboratory at the Armed Forces Medical Examiners System at Dover Air Force Base in Delaware.

Tease photo

Shares Rise After Otonomy's $100M IPO

Shares of Otonomy Inc. were rising Aug. 13 after the biotech drug developer's initial public offering raised $100 million.

Tease photo

Cytori Therapeutics Nets $11.8M Loss for 2Q

Cytori Therapeutics Inc. reported a net loss of $11.8 million for second quarter 2014, down from a net loss $3.2 million during the same period in 2013.

Tease photo

Suffolk Completes $13 Million Family Health Center

The opening of the 23,000-square-foot medical office building was celebrated with a public event.

Tease photo

Scripps Research Names Paulson Acting President and CEO

The Scripps Research Institute appointed James Paulson, chair of its Department of Cell and Molecular Biology, as acting president and CEO, the institute’s board of trustees announced Monday.

Tease photo

Ligand to Offer $225 Million in Senior Convertible Notes, Authorizes $200M Share Buyback

San Diego-based Ligand Pharmaceuticals Inc. announced that it intends to offer $225 million of convertible senior notes due 2019 and has authorized a $200 million share repurchase program over the next 12 months.

Tease photo

Ignyta Names Chief Medical Officer

San Diego-based cancer drug developer Ignyta Inc. has appointed Adrian Senderowicz as chief medical officer and senior vice president of clinical development and regulatory affairs.

Tease photo

ViaCyte Raises $5.4 Million in Private Financing

ViaCyte Inc. has announced it has raised $5.4 million in private financing to pursue the clinical development of its artificial pancreas, which could treat type 1 diabetes.

Tease photo

Kaiser’s New Hospital to Bring 450 Beds to San Diego Market

MEDICINE: Increasing Demand to Be Met By New Facility, Upgrades

Kaiser Permanente’s new 450-bed hospital in Kearny Mesa will feature cutting-edge technology and innovative communication strategies while relieving the growing pressure on its current facilities.

Tease photo

Operation Changes

Walking through the old mansion-converted City Hall in Amsterdam, N.Y., a young Tim Moran climbed into the gated elevator and braced himself when the elevator shook and creaked to a halt — stalled between floors.

Tease photo

DexCom Announces Data Integration Relationship With Asante

Asante Solutions Inc., a Sunnyvale-based medical device company manufacturing an insulin pump, has announced its intention to use DexCom Inc.’s mobile platform to integrate and display insulin data.

Google Executive Brings Big Data Skills to Human Longevity

BIOTECH: Interpreting Massive Genetic Sequencing Information Is the Challenge

A San Diego startup founded by human genomics pioneer J. Craig Venter has recruited Franz Och, former leader of Google Translate and expert in machine learning, to find new ways to crunch and interpret human sequencing data.

Local Company Takes a Leading Role in Fight Against Ebola

BIOTECH: Mapp Provided Its Experimental Serum to Infected Missionaries

Mapp Biopharmaceutical Inc., a San Diego-based company with only nine employees, made international headlines last week for its role in developing an experimental Ebola treatment that may save the lives of two American aid workers who contracted the virus in Liberia.